Health Sciences Library Offering Workshops from the National Center for Biotechnology Information
The University of Cincinnatis
Donald C. Harrison Health Sciences Library
(HSL) is partnering with the National Center for Biotechnology Information (NCBI) to bring to campus a series of workshops to educate researchers on a number of databases housed within the NCBI domain.
The workshops will be held at various times between 9 a.m.-4 p.m. Nov. 8-9 and between 1 p.m.-4 p.m. Nov. 10 in Kresge Auditorium in the College of Medicine. A complete schedule is available online at
http://libapps.libraries.uc.edu/sites/ncbi/schedule/
. Each workshop will be three hours long and facilitated by NCBI experts and trainers. Workshop topics include: a practical guide to NCBI Blast; accessing genomes, assemblies and annotation products; accessing NCBI human variation and medical genetics resources; exploring gene expression information at the NCBI and principles of PubChem.
Each workshop is free and open to the public but may be of particular interest to faculty and researchers in medicine, biology, chemistry and related fields. More information about the workshops and trainers, the complete schedule and a link to registration can be found at
http://libapps.libraries.uc.edu/sites/ncbi/
.
As a national resource for molecular biology information, NCBI's mission is to develop new information technologies to aid in the understanding of fundamental molecular and genetic processes that control health and disease. To achieve their mission, NCBI conducts research; collaborates with institutes, academia, industry and other governmental agencies; sponsors meetings, workshops and lecture series; and develops, distributes, supports and coordinates access to a variety of databases and software for the scientific and medical communities.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Designing with cancer patients' needs in focus
August 27, 2026
Kristina Shin is designing garments that prioritize the comfort, function and confidence of breast cancer patients, addressing a need often overlooked by traditional fashion.